
A two-drug combination has been shown to improve patient response to treatment in relapsed or refractory acute myeloid leukemia.

Investigators have developed a new imaging technique that increases the detection and identification of proteoforms by four-fold when compared to current methods.

Investigators have identified distinct epigenetic pathways in African American and European American patients diagnosed with multiple myeloma, according to a Northwestern Medicine study.

A Northwestern Medicine study has identified a molecular mechanism that helps regulate the progression of castration-resistant prostate cancer.

After a pediatric cancer diagnosis, chances of infections remain elevated for more than a decade, according to a recent study.

A change in function in a mitochondrial protein is associated with gene expression that may promote the development of cancer, according to a recent Northwestern Medicine Study.

A new Northwestern Medicine trial will test whether a telehealth-based intervention that addresses three behavioral risk factors at once can modify cancer patients’ lifestyles to improve their outcomes.

An inflammatory signaling protein called interleukin-6 has been linked to the progression of acute myeloid leukemia, representing a potential target for future treatments of the disease.

An emerging therapy showed promise in patients with relapsed B-cell lymphoma who are not ideal candidates for stem cell transplants.

A new study has identified a molecular switch, through a protein called CDK9, that plays an early and critical role in the skin stem cell differentiation process.